Because polycythemia may require dose reductions or discontinuation of therapy, hematocrit should be obtained at baseline, 3 to 6 months after initiation of therapy, and annually thereafter.

由于红细胞增多可能需要降低剂量或停止治疗，故应在开始治疗前、初始治疗后的3 ~6个月以及随后的每年检测红细胞比积。

youdao

Because polycythemia may require dose reductions or discontinuation of therapy, hematocrit should be obtained at baseline, 3 to 6 months after initiation of therapy, and annually thereafter.

由于红细胞增多可能需要降低剂量或停止治疗，故应在开始治疗前、初始治疗后的3 ~6个月以及随后的每年检测红细胞比积。

youdao